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K. Mohanty, Kanu Chatterjee. Nardev S. Khurmi, Jay N. Cohn. University ofFlorida,
Gainesville, FL
Effects of stable. selective A, adenosine receptor agonist (N6_cyc lohexyl-
2'-0-methyladenosine) SDZ WAG 994 were investigated in a randomized,
double-blind, placebo-controlled, parallel group. multicenter study. After
baseline hemodynamic and neurohormone data were obtained in 50 patients
(mean age 56 years) with left ventricular dysfunction (mean EF 30%). who
were NYHA Class I (32%) or II (68%). they received either I, 2 or 5 mg of
SDZ WAG 994 or placebo orally. Hemodynamic data were collected every 30
minutes for 4 hours and then every 2 hours for 20 hours. Neurohormones
and plasma drug concentration were measured 2 hours after dosing.
The active drug was clinically well tolerated as there were no significant
differences comparing adverse events reported with placebo and the 3 ac-
tive drug doses. No important effects were seen on systolic, right atrial. pul-
monary artery or pulmonary artery wedge pressures, cardiac index, or heart
rate. The PR interval increased slightly with the 5 mg dose (176 to 193 msec
at 2 hrs). Atrial natriuretic peptide (ANP) levels increased significantly (216
± 137 to 407 ± 146 pgfmL, p < 0.01) with the 5 mg dose and increases
of lesser magnitude occurred with 1 and 2 mg doses. Interestingly, plasma
norepinephrine also increased with the 5 mg dose (477 ± 243 to 618 ± 237
pglmL, p < 0.01). No significant changes occurred in plasma renin activity Or
epinephrine levels.
In summary, selective A, adenosine receptor agonism, evidenced by an in-
crease in PR interval and plasma ANP. was safely achieved for several hours
in patients with LV dysfunction. Significant neurohormonal effects were ob-
served with no important hemodynamic changes. Both A, adenosine ag-
onism and ANP have been shown to attenuate hypoxic cell damage and
vasoconstriction and this agent could have clinical utility in ischemic heart
disease.
Thomas C. Andrews. John D. Parker. Richard Friedman, Sue Jacobs.
Nancy Cummings. Gail MacCallum, Geoffrey H. Tofler. James E. Muller, Peter
H. Stone. Brigham and Women's Hospital, Boston, MA
Previous investigators have demonstrated that mental stress can induce my-
ocardial ischemia in selected patients with coronary disease manifested by
new wall motion abnormalities on radionuclide ventriculography. It is un-
known whether such ischemia is due to coronary vasoconstriction or to in-
creased myocardial O2 demand. We studied the effect of nifedipine GITS
and atenolol as single-agent therapy on mental stress-induced ischemia
in a double-blind. placebo-controlled, three-way crossover trial in 16 pa-
tients with stable angina. Each patient received maximally tolerated doses
of nifedipine (mean daily dose: 88 mg). atenolol (mean daily dose: 91 mg)
or placebo during each of 3 4-week treatment phases. At the end of each
phase. patients underwent a mental stress procedure (Stroop color word
test, mental arithmetic. and stress interview) with skin conductance moni-
tored to gauge physiologic arousal. Left ventricular wall motion was graded
in each of 5 regions using a scale from 3 (normal) to -1 (dyskinesis), and by
regional ejection fraction. The segment with the largest deterioration in wall
motion during placebo therapy was determined, and the effects of nifedipine
and atenolol on this segment were compared. Results: Mental stress caused
a significant increase in skin conductance levels, with peak values similar on
each therapy. Therapy with either nifedipine or atenolol prevented a dete-
rioration in wall motion score (-0.6 for placebo; 0.0 for nifedipine. 0.0 for
atenolol, each p < 0.01 vs. placebo). while only nifedipine prevented a sig-
nificant decrease in regional ejection fraction (-13.0% on placebo; -5.6%
for atenolo!. p = 0.08 vs. placebo; -1.9% on nifedipine, p = 0.01 vs placebo,
p ~ 0.4 vs. atenolol). The rate pressure product (heart rate x systolic blood
pressure. RPP) at peak mental stress (Le.. peak myocardial 02 demand)was
15.792 on placebo, and was reduced only by atenolol (12,287, p = 0.001).
but not by nifedipine (15,185, p ~ NS). Conclusion: Both nifedipine GITS
and atenolol are effective at preventing mental stress-induced ischemic wall
motion abnormalities. although the mechanisms may be different. Nifedipine
improved reg'lonal wall motion without reducing RPP. and thus may have pre-
vented mental stress-induced coronary vasoconstriction. Atenolol improved
regional wall motion and reduced RPP. and thus may have been effective by
reducing myocardial O2 demand.
Ad F.M. van den Heuvel, Martin van der En!, Willem J. Remme. Sticares Foundation,
Rotterdam. The Netherlands
Long-term Effects of Amlodlpine and
Isosorblddinltrate on Exercise-Induced and
Ambulatory Ischaemia In Patients with Stable
Angina Pectoris
Enalapril Does not Affect Ischemia During
Short·term Treatment in Stable Angina Pectoris
Irrespective of Its Effect on Blood Pressure
Whereas ACE inhibition acutely reduces myocardial ischemia (MI) through
neuroendocrine modulation and, after long-term treatment (1 year), affects
ischemic events in LV dysfunction. the short-term anti ischemic properties in
chronic, stable anginal patients and normal LV function are debated. As a
pro-ischemic effect may be explained by lowering coronary artery perfusion
pressure, the effects of enalapril (E) 10 mg b.i.d. on ischemia in relation to
blood pressure (BP). and placebo b.Ld. were compared in 27 patients with
chronic exercise-induced angina pectoris in a double-blind cross-over trial
with 2 treatment periods of 2 weeks each. Exercise performance was as-
sessed using treadmill exercise tests. No period or treatment sequence ef-
fects were observed for BP. heart rate and exercise performance. After treat-
ment with E. resting systolic and diastolic BP were 7% and 6%, respectively,
lower compared to placebo. During maximal exercise. systolic BP and rate-
pressure product (RPP) were similar during both treatments, whereas dias-
tolic BP was 6% less with E. Maximal workload was comparable after both
treatment periods. No differences between treatment were seen with regard
to exercise duration. time to angina. maximal ST-depression (0.2 mV in both
groups) and time to 0.1 mV ST-depression. When patients were divided into
2 groups according to BP response on an initial dose of 10 mg E, 11 pts:::
20 mmHg and 16 pts < 16 mmHg, still no differences during exercise were
found. Thus. in stable chronic exercise-induced angina. short-term E does
not decrease myocardial ischemia, irrespective of first-dose BP response.
Also, no pro-ischemic effects as a result of lowering coronary artery perfu-
sion pressure were observed.
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The autonomic nervous system plays an important role in the occurrence of
symptomatic and silent myocardial ischemia (MI) during daily life. Analysis of
heart rate variability (HRV) is a non-invasive tool which provides information
on autonomic control. We investigated if analysis of HRV can be used to pre-
dict the efficacy of drug treatment of MI in a double-blind, cross-over study.
Twenty eight patients with stable angina pectoris, proven coronary artery
disease and MI during Holter monitoring received metoprolol controlled re-
lease 200 mg once daily and diltiazem 60 mg 4 times daily. After a placebo
phase and after each treatment period. 72 hour Holter recordings were per-
formed for analysis of HRVand MI. HRV analysis included standard deviation
Rolf Steffensen, Thomas Melchior, Jan Bech. Henrik Nissen. Bennedicte Haastrup.
Peer Grande, Verner Rasmussen. J",gen F. Hansen, Knud Skagen,
Torben Haghfelt. University of Copenhagen and University of Odense, Denmark
Once-daily administration of 10 rng amlodipine has been compared with two
daily doses of 40 mg sustained-release isosorbiddinitrate (ISDN) in 59 pa-
tients with stable angina, using a randomized, double-blind, double-placebo.
crossover study design. Nine patients dropped out due to side effects (3 dur-
ing amlodipine and 6 during ISDN therapy). and one patient was excluded for
technical reasons.
A maximal symptom limited supine bicycle tolerance test and a 48 h am-
bulatory ECG monitoring were performed at the end of each 5 week period
of therapy. During exercise, exercise time, time to onset of angina, and time
to onset of ischaemia, Le., 1 mm ST segment depression were measured.
During ambulatory monitoring. number of anginal episodes and duration per
hour of ST deviation were assessed.
Amlodipine significantly prolonged time to angina (320 ± 155 vs 304 ±
126 sec; p < 0.05) and time to ischaemia (292 ± 153 vs 232 ± 126 sec;
p < 0.001). when compared with ISDN, while exercise time was similar for
both treatments. Furthermore, amlodipine reduced anginal episodes (1.2 ±
1.6 vs 2.4 ± 3.0 attacksf48 h; p < 0.001). whereas. no difference was found
between amlodipine and ISDN in duration of ST deviation during ambulatory
monitoring.
In conclusions, addressing the long-term treatment of patients with stable
angina pectoris. once-daily dosing of amlodipine appears to be more effec-
tive than ISDN, as determined by its anti-anginal and anti-ischaemic effects
during exercise tolerance testing and ambulatory ECG monitoring.
Analysis of Heart Rate Variability may Predict
Efficacy of Metoprolol in the Treatment of
Myocardial Ischemia During Daily Life
Jan Brouwer. Jan W. Viersma. Dirk J. van Veldhuisen, Arie J. Man in 't Veld,
Pieter Sijbring, Jaap Haaksma, W. Arnold Dijk, Kong I. Lie. Department of
Cardiology, University Hospital Groningen. The Netherlands
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Prevention of Mental Stress-induced Wall Motion
Abnormalities by Nifedipine GITS and Atenolol
Therapy
Neurohormonal and Hemodynamic Effects of
SDZ WAG 994 a Novel Selective A,
Adenosine-receptor Agonist in Patients with
Heart Failure
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Myocardial Preconditioning During Repeated
Daily Ischemic Episodes
FOP vs baseline: *p < 0.05, **p < 0.01; FOP vs placebo: +p < 0.05, ++p < 0.01, +++p
< 0.001
Conclusion. These results indicated that FOP is beneficial to patients
with stable angina pectoris. It prolongs exercise duration, decreases angi-
nal episodes and total ischemic burden.
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Dan Tzivoni, Simon Maybaum, Noemie Bloch, Michaeilian. Jesselson Heart Center,
Shaare Zedek Medical Center, Jerusalem, Israel
Myocardial preconditioning was described in animal experiments and also
on repeated coronary occlusions during coronary angioplastv, however, it
has never been described during daily life. Twenty-three patients with proven
coronary disease and episodes of ischemia on Holter monitoring were in-
structed to walk the same route, which previously caused myocardial is-
chemia, 3 times within 45 minutes (15 minutes each walk). The duration of
ischemia (per patient), maximal ST depression (STD), and the ST level at a
uniform heart rate (normalized STD) for all 3 walks for every patient were
recorded.
Reduction in Exercise Threshold to Post-prandial
Angina Occurs After Carbohydrate, but not Fat or
Protein, and Independently of Myocardial Oxygen
Consumption
Ragavendra R. Baliga, Leah J. Burden, Jaspal S. Kooner. Royal Postgraduate
Medical School, Hammersmith Hospital, London, UK.
(SDNN), coefficient of variation, rMSSD and pNN50. Spectral analysis using
a Fourier transform algorithm resulted in total power, low (0.04-0.15 Hz) and
high (0.15-0.40 Hz) frequency components.
At baseline, the total duration of MI was 11.4 ± 13.9 minutes (mean per 24
hours ± SOl, the total number of episodes was 2.2 ± 2.3. Metoprolol reduced
the total duration of MI -6.0 minutes (-11.1, -1.0), (mean per 24 hours and
95% CII; the total number of episodes decreased -1.3 (-2.2, -0.5). These
changes were significantly more pronounced in patients with a low SDNN at
baseline: the total duration of MI decreased -8.7 minutes (-14.5, -2.8) and
the total number of episodes -1.9 (2.9, -0.8). In patients with a high SDNN at
baseline, however, only non significant trends were observed. Similar results
were obtained when patients were divided using the other HRV parameters,
but not when using heart rate at baseline. Furthermore, similar results were
also found for changes in silent MI. Diltiazem reduced only the total duration
of MI by -4.9 min{-9.7, -0.1). the other parameters did not show significant
changes. Also, no significant changes were observed in relation to HRV
We conclude therefore, that especially patients with reduced HRV at base-
line respond to treatment with metoprolol. This differential pattern is not ob-
served with diltiazem. Our results indicate, that analysis of HRV can be useful
in selecting patients who will benefit from treatment with beta blockers.
Yang Li, Hai-ming Shi, Yue-wen Xi, Shou-yi Wang, Wei-hu Fan, Rui-hong Dai.
Shanghai Medical University, Shanghai, PH China
Angina 1 mmSTDEP Peak Exercise
TA (secl RPP x 10-3 TST (sec) RPP x 10-3 Time (sec) RPP x 10-3
WM 141 ± 20 16 ± 07 141 ± 20 17 ± 1.2 317 ± 62 18 ± 1.2
eM 109±17' 18± 10 109 ± 17' 18± 1.4 254 ± 66* 20 ± 1.2
FM 157 ± 59 17 ± 1.0 157 ± 21 19± 1.2* 287 ± 62 20± 12
PM 149 ± 64 18 ± 0.5* 149 ± 22 18 ± 1.0 291 ± 65 20 ± 1.1*
Conclusion: 1. Decrease in time to angina, 1 mm ST DEP. and peak ex-
ercise occur after carbohydrate meal but not fat meal or protein meal. 2.
This is not accompanied by a rise in rate-pressure product after carbohy-
drate meal unlike fat meal and protein meal. 3. Decreased exercise threshold
to post-prandial ischaemia after carbohydrate meal occurs independently of
increased myocardial oxygen consumption, suggesting 'steal' mechanisms
contribute.
Post SOD
37 ± 8*
53 ± 17*
Pre SOD
Area AFR
150 ± 39
184 ± 26
5 ± 2*
6 ± 2*
Post SOD
Antioxidant Enzymes Attenuate Free Radical
Generation After Direct Current Countershocks
% 6.AFR
17 ± 4
20 ± 5
Pre SOD
Walk p
1 2 3 walk 1 vs 2 walk 1 vs 3
Ischemia Duration (secl 514 228 253 0.003 0.003
Maximal STD (mm) 2.21 161 1.43 0.001 0.0002
Normalized STD (mml 1.95 1.41 118 0.0002 0.00001
Max. Heart Rate (b/min) 113 112 113 0.793 0.974
These data indicate that during repeated ischemic episodes, for the same
maximal heart rates, there was a reduction in duration of ischemia, in maxi-
mal ST depression and a reduction in the normalized STD.
This is the first description of myocardial preconditioning during daily life,
and it may provide explanation for the well-known phenomenon of "walk-
through-angina".
Chest Pain Follow Up After Emergency
Treatment/Cardiopulmonary Resuscitation
Tuesday, March 21,1995, Noon-2:00 p.m.
Ernest N. Morial Convention Center, Hall E
Presentation Hour: 1:00 p.m.-2:00 p.m.
Matthew R. Caterine, Kirk T. Spencer, Robin S. Smith, Garry R. Buettner, Richard
E. Kerber. Univ. of Iowa, Iowa City, IA
Previous work in our lab has shown that direct current (DC) shocks gener-
ate free radicals, which may be toxic to the myocardium. We hypothesized
that administration of free radical scavenging enzymes prior to shock deliv-
ery would attenuate the generation of free radicals. We used a newly devel-
oped and validated technique for real time quantitation of free radical pro-
duction: ascorbyl free radical (AFR) concentration in coronary sinus blood,
measured by electron paramagnetic resonance. In 10 open-chest dogs, 75J
and 100J epicardial shocks were administered during NSR. Then superoxide
dismutase (SOD, 15,000 f.L!kg) and catalase (CAT. 55,000 u!kg) were given as
a continuous infusion. Ten mins. after initiating the SODICAT infusion, 75J
and 100J shocks were repeated. Four control dogs received normal saline
instead of SODICAT.
Results:
75 J
100 J
Energy
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Effects of Fructose-1,6-Diphosphate in Patients
with Stable Angina Pectoris
We investigated the role of food constituents in mechanisms contributing
to post-prandial angina (PPA). Studies were performed in 8 males (aged 60
± 3 yrs). with reproducible PPA, after an overnight fast. off drugs (except
GTN) for 3 days. HR, BP. rate pressure product (RPPI, time to onset of angina
(TA) and 1 mm ST depression (TST), plasma noradrenaline (NOR, nmolll) and
adrenaline (AD, nmolM, were measured before, 30 min after water (WM). liq-
uid carbohydrate (eM), fat (FM). and protein (PM) meals, and during exercise
(Bruce protocol). Meals were isocaloric (1 000 cal). isovolumic, and adminis-
tered in random order, on separate days. HR, BP. and RPP increased to similar
levels 30 min after CM, FM and PM, compared to WM. During exercise TA.
TST and ED were reduced after CM, but not FM or PM, compared to WM (*
~ p < 0.05). RPP was unchanged after CM, but increased after FM and PM,
compared to WM. Plasma NOR rose after CM (3.4 ± 0.4 to 4.9 ± 04*) and
FM (3.1 ± 0.3 to 4.2 ± 0.2*), but not after PM or WM. Plasma AD did not rise
after meals.
Experimental studies showed that fructose-1,6-diphosphate (FOP) supplied
exogenously improved hemodynamic parameters, attenuated electrocardio-
graphyassessed injury and loss of ATP from ischemic myocardium. The ef-
fects of FOP were evaluated in 42 patients with stable angina pectoris using
a double blind, placebo-controlled, crossover trial design. After their angina
was stabilized, the patients were randomly assigned to sequence group A
or B. Group A received a placebo intravenously (iv) 2 times daily for 10 days
and then FOP 109 iv. 2 times daily for 10 days. Group B received the same
treatment in the reverse order. Treadmill exercise tests and Holter-monitoring
were performed before and in the last two days of placebo or FOP treatment.
The differences in outcome between placebo and FOP were the following.
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x ± SO.. *p < 0,05 post V5. pre. Area = integrated area under AFR concentration vs. time
curve
